440 related articles for article (PubMed ID: 30045635)
1. Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research.
Zhen S; Li X
Hum Gene Ther; 2019 Jan; 30(1):3-9. PubMed ID: 30045635
[TBL] [Abstract][Full Text] [Related]
2. Genetic Editing of Long Noncoding RNA Using CRISPR/Cas9 Technology.
Larter K; Yi B; Xi Y
Methods Mol Biol; 2021; 2372():169-177. PubMed ID: 34417751
[TBL] [Abstract][Full Text] [Related]
3. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research.
Aquino-Jarquin G
Cancer Res; 2017 Dec; 77(24):6812-6817. PubMed ID: 29208606
[TBL] [Abstract][Full Text] [Related]
4. Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening.
Esposito R; Bosch N; Lanzós A; Polidori T; Pulido-Quetglas C; Johnson R
Cancer Cell; 2019 Apr; 35(4):545-557. PubMed ID: 30827888
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9 therapies in experimental mouse models of cancer.
Estêvão D; Rios Costa N; da Costa RG; Medeiros R
Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies.
Zhang F; Zhang L; Zhang C
Tumour Biol; 2016 Jan; 37(1):163-75. PubMed ID: 26586396
[TBL] [Abstract][Full Text] [Related]
7. In Vivo CRISPR/Cas9-Based Targeted Disruption and Knockin of a Long Noncoding RNA.
Cheng X; Peters ST; Pruett-Miller SM; Saunders TL; Joe B
Methods Mol Biol; 2021; 2254():305-321. PubMed ID: 33326084
[TBL] [Abstract][Full Text] [Related]
8. Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology.
Mahato RK; Bhattacharya S; Khullar N; Sidhu IS; Reddy PH; Bhatti GK; Bhatti JS
J Biotechnol; 2024 Jan; 379():98-119. PubMed ID: 38065367
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z
RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415
[TBL] [Abstract][Full Text] [Related]
10. Tuning the Expression of Long Noncoding RNA Loci with CRISPR Interference.
Stojic L
Methods Mol Biol; 2020; 2161():1-16. PubMed ID: 32681501
[TBL] [Abstract][Full Text] [Related]
11. Challenges of CRISPR/Cas9 applications for long non-coding RNA genes.
Goyal A; Myacheva K; Groß M; Klingenberg M; Duran Arqué B; Diederichs S
Nucleic Acids Res; 2017 Feb; 45(3):e12. PubMed ID: 28180319
[TBL] [Abstract][Full Text] [Related]
12. Applications and advances of CRISPR-Cas9 in cancer immunotherapy.
Xia AL; He QF; Wang JC; Zhu J; Sha YQ; Sun B; Lu XJ
J Med Genet; 2019 Jan; 56(1):4-9. PubMed ID: 29970486
[TBL] [Abstract][Full Text] [Related]
13. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
Wu HY; Cao CY
Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9 to Silence Long Non-Coding RNAs.
Rosenlund IA; Calin GA; Dragomir MP; Knutsen E
Methods Mol Biol; 2021; 2348():175-187. PubMed ID: 34160807
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Insulin Resistance Related ceRNA Network in T2DM and Its Potential Editing by CRISPR/Cas9.
Matboli M; Kamel MM; Essawy N; Bekhit MM; Abdulrahman B; Mohamed GF; Eissa S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360895
[TBL] [Abstract][Full Text] [Related]
16. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Jiang C; Meng L; Yang B; Luo X
Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs as novel therapeutic targets in cancer.
Lavorgna G; Vago R; Sarmini M; Montorsi F; Salonia A; Bellone M
Pharmacol Res; 2016 Aug; 110():131-138. PubMed ID: 27210721
[TBL] [Abstract][Full Text] [Related]
18. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
Liu C; Zhang L; Liu H; Cheng K
J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
[TBL] [Abstract][Full Text] [Related]
19. The emerging molecular biology toolbox for the study of long noncoding RNA biology.
Fok ET; Scholefield J; Fanucchi S; Mhlanga MM
Epigenomics; 2017 Oct; 9(10):1317-1327. PubMed ID: 28875715
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
